Endocrine Disruptors and Obesity: An Overview.
Murro I, Lisco G, Di Noia C, Lampignano L, Zupo R, Giagulli VA, Guastamacchia E, Triggiani V, De Pergola G.
Murro I, et al. Among authors: di noia c.
Endocr Metab Immune Disord Drug Targets. 2022;22(8):798-806. doi: 10.2174/1871530322666220328122300.
Endocr Metab Immune Disord Drug Targets. 2022.
PMID: 35346017